Search research articles
Contact Us
Filters
Showing results (21-30 of 77) with videos related to
Page
of 8
Sort By:
British Journal of Haematology
|
August 24, 2017
Real world data of the impact of first cycle daratumumab on multiple myeloma and AL amyloidosis services
Rakesh Popat, Emma Dowling, Sufyan Achhala, et al.
British Journal of Haematology
|
February 23, 2024
Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper
Daniel Hughes, Kwee Yong, Karthik Ramasamy, et al.
Annals of Hematology
|
October 28, 2014
Bendamustine in combination with thalidomide and dexamethasone is a viable salvage option in myeloma relapsed and/or refractory to bortezomib and lenalidomide
I-Jun Lau, Dean Smith, Robin Aitchison, et al.
BMJ Open Quality
|
January 6, 2025
Real-world evaluation of physiotherapist-led exercise prehabilitation and rehabilitation during autologous stem cell transplantation in myeloma: a single-centre experience
Joanne Land, Michael K Luong, Alasdair Longden, et al.
Plos One
|
September 7, 2012
Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myeloma
Clive Henry Buckle, Evy De Leenheer, Michelle Anne Lawson, et al.
British Journal of Haematology
|
April 20, 2012
Re-infused lymphocyte dose does not influence disease control following upfront autologous stem cell transplantation for multiple myeloma
Laura A Percy, Sally E Moore, Wendi Qian, et al.
BMC Cancer
|
July 13, 2016
Spinal disease in myeloma: cohort analysis at a specialist spinal surgery centre indicates benefit of early surgical augmentation or bracing
Karan Malhotra, Joseph S Butler, Hai Ming Yu, et al.
European Radiology
|
January 14, 2022
Application of diffusion-weighted whole-body MRI for response monitoring in multiple myeloma after chemotherapy: a systematic review and meta-analysis
Kaiwen Wang, Elsa Lee, Shedrack Kenis, et al.
Journal of the Peripheral Nervous System : JPNS
|
January 5, 2011
Bortezomib-induced inflammatory neuropathy
Tabish A Saifee, Kathryn J Elliott, Neil Rabin, et al.
British Journal of Haematology
|
December 29, 2018
Clinical benefit of depth of response for relapsed/refractory multiple myeloma patients treated on clinical trials: retrospective analysis from two tertiary centres
Esther H L Chan, Dunnya De-Silva, Adeline H F Lin, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 77) with videos related to
Sort By:
Page
of 8
British Journal of Haematology
|
August 24, 2017
Real world data of the impact of first cycle daratumumab on multiple myeloma and AL amyloidosis services
Rakesh Popat, Emma Dowling, Sufyan Achhala, et al.
British Journal of Haematology
|
February 23, 2024
Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper
Daniel Hughes, Kwee Yong, Karthik Ramasamy, et al.
Annals of Hematology
|
October 28, 2014
Bendamustine in combination with thalidomide and dexamethasone is a viable salvage option in myeloma relapsed and/or refractory to bortezomib and lenalidomide
I-Jun Lau, Dean Smith, Robin Aitchison, et al.
BMJ Open Quality
|
January 6, 2025
Real-world evaluation of physiotherapist-led exercise prehabilitation and rehabilitation during autologous stem cell transplantation in myeloma: a single-centre experience
Joanne Land, Michael K Luong, Alasdair Longden, et al.
Plos One
|
September 7, 2012
Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myeloma
Clive Henry Buckle, Evy De Leenheer, Michelle Anne Lawson, et al.
British Journal of Haematology
|
April 20, 2012
Re-infused lymphocyte dose does not influence disease control following upfront autologous stem cell transplantation for multiple myeloma
Laura A Percy, Sally E Moore, Wendi Qian, et al.
BMC Cancer
|
July 13, 2016
Spinal disease in myeloma: cohort analysis at a specialist spinal surgery centre indicates benefit of early surgical augmentation or bracing
Karan Malhotra, Joseph S Butler, Hai Ming Yu, et al.
European Radiology
|
January 14, 2022
Application of diffusion-weighted whole-body MRI for response monitoring in multiple myeloma after chemotherapy: a systematic review and meta-analysis
Kaiwen Wang, Elsa Lee, Shedrack Kenis, et al.
Journal of the Peripheral Nervous System : JPNS
|
January 5, 2011
Bortezomib-induced inflammatory neuropathy
Tabish A Saifee, Kathryn J Elliott, Neil Rabin, et al.
British Journal of Haematology
|
December 29, 2018
Clinical benefit of depth of response for relapsed/refractory multiple myeloma patients treated on clinical trials: retrospective analysis from two tertiary centres
Esther H L Chan, Dunnya De-Silva, Adeline H F Lin, et al.
Page
of 8